indazoles has been researched along with Brill-Symmers Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andorsky, DJ; Assouline, S; Forero-Torres, A; Jones, V; Klein, LM; Kolibaba, KS; Patel-Donnelly, D; Sharman, JP; Shi, W; Smith, M; Yasenchak, CA; Ye, W | 1 |
| Alessi, DR; Duce, SL; Fleming, S; García-Martínez, JM; Guichard, S; Preston, G; Wullschleger, S | 1 |
| Duce, SL; García-Martínez, JM; Wullschleger, S | 1 |
1 trial(s) available for indazoles and Brill-Symmers Disease
| Article | Year |
|---|---|
An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Indazoles; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Male; Middle Aged; Neoplasm Proteins; Pyrazines; Syk Kinase; Waldenstrom Macroglobulinemia | 2019 |
2 other study(ies) available for indazoles and Brill-Symmers Disease
| Article | Year |
|---|---|
Effect of PI3K- and mTOR-specific inhibitors on spontaneous B-cell follicular lymphomas in PTEN/LKB1-deficient mice.
Topics: AMP-Activated Protein Kinases; Animals; Indazoles; Lymphoma, B-Cell; Lymphoma, Follicular; Mice; Mice, Inbred C57BL; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; PTEN Phosphohydrolase; Signal Transduction; Sulfonamides; TOR Serine-Threonine Kinases | 2011 |
Quantitative MRI establishes the efficacy of PI3K inhibitor (GDC-0941) multi-treatments in PTEN-deficient mice lymphoma.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Enzyme Inhibitors; Female; Head and Neck Neoplasms; Indazoles; Longitudinal Studies; Lymphoma, B-Cell; Lymphoma, Follicular; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phosphoinositide-3 Kinase Inhibitors; PTEN Phosphohydrolase; Sulfonamides | 2012 |